Hyaluronic Acid Sodium Salt: ECM Function & siRNA Delivery Evidence

Executive Summary: Hyaluronic acid sodium salt (also known as sodium hyaluronate) is a high-molecular-weight, anionic glycosaminoglycan critical to extracellular matrix (ECM) integrity and viscoelasticity (product information). It enables lubrication and shock absorption in synovial fluid, and modulates cell signaling, including PI3K-Akt pathways. Recent preclinical studies demonstrate its value as a carrier for siRNA nanoparticles, targeting immune cell function and infection outcomes (Nature Communications, 2026). In vitro and in vivo applications leverage its ability to localize proteolytic enzymes and facilitate tissue remodeling. APExBIO supplies high-purity hyaluronic acid sodium salt (B8382), supporting reproducibility in ECM modeling and nanodelivery research.

Biological Rationale

Hyaluronic acid sodium salt is a major, nonsulfated glycosaminoglycan found in connective, epithelial, and neural tissues, where it forms a structural backbone of the extracellular matrix (product information). Its repeating disaccharide units (D-glucuronic acid and N-acetyl-D-glucosamine) create a highly hydrophilic, space-filling polymer. This ECM component maintains tissue hydration, provides viscoelasticity, and supports mechanical integrity in organs and joints. Its biological significance is further underscored by its role in modulating cellular responses, including proliferation, migration, and adhesion. In disease models, elevated hyaluronic acid levels are associated with tumor invasion, angiogenesis, and tissue repair processes (see related article). This article extends those findings by directly benchmarking the use of high molecular weight sodium hyaluronate in nanoparticle-mediated siRNA delivery and immune modulation.

Mechanism of Action of Hyaluronic acid sodium salt

Hyaluronic acid sodium salt acts through both biophysical and signaling pathways. Its polyanionic structure enables it to retain water, creating a lubricating matrix in synovial fluid and supporting shock absorption in articular cartilage (product details). At the molecular level, it interacts with cell surface receptors (e.g., CD44, RHAMM) to influence PI3K-Akt pathway activation, which governs cell survival, migration, and inflammation. Mechanistically, hyaluronic acid facilitates the localization of matrix metalloproteases (e.g., MMP-9) at the cell surface, thereby regulating ECM turnover and tissue remodeling. In nanoparticle systems, hyaluronic acid forms a biocompatible coating that enhances siRNA delivery to target cells, improves endosomal escape, and enables receptor-targeted uptake. In the context of infection and immune modulation, hyaluronic acid-coated nanoparticles have been shown to direct siRNA to neutrophils, alter cell death pathways (e.g., cuproptosis), and reduce inflammatory injury (Nature Communications 2026). For further mechanistic insight, the article "Hyaluronic Acid Sodium Salt in siRNA Delivery & ECM Modeling" details how this biopolymer bridges structural and immunomodulatory research needs; here, we update those findings with direct evidence from recent infection models.

Evidence & Benchmarks

• High-molecular-weight hyaluronic acid sodium salt (1000–1500 kDa) is insoluble in ethanol, DMSO, and water, requiring specialized preparation for biological assays (product info).
• In preclinical models of Pseudomonas aeruginosa lung injury, hyaluronic acid-coated siRNA nanoparticles targeting TDRD9 reduce pulmonary neutrophil accumulation, bacterial burden, and inflammatory damage (DOI).
• Hyaluronic acid sodium salt modulates PD-L1/CD80/MAPK signaling in neutrophils, promoting cuproptosis and attenuating lung pathology in both mouse and human organoid systems (DOI).
• Concentration-dependent effects are observed in vitro, with biological activity reported at nanomolar to micromolar concentrations, dependent on molecular weight and assay configuration (product documentation).
• As a carrier, hyaluronic acid sodium salt improves siRNA stability, cellular uptake, and target selectivity compared to naked RNA (related article).

Applications, Limits & Misconceptions

Hyaluronic acid sodium salt is widely used in:

• Cell-based assays for modeling ECM and cell adhesion dynamics
• Formulation of nanoparticles for targeted siRNA or small molecule delivery
• Immune modulation studies, particularly in infection and cancer models
• Joint lubrication and tissue engineering research, leveraging its viscoelastic properties

Despite its versatility, hyaluronic acid sodium salt has limitations. It is insoluble in common laboratory solvents, requiring precise protocol design. Long-term storage of solutions is not recommended due to viscosity changes and potential degradation (see APExBIO product B8382 guidelines). Not all cell types express the required receptors for targeted delivery, and the efficacy of hyaluronic acid-based nanoparticles can vary with molecular weight and formulation.

Common Pitfalls or Misconceptions

• Assuming universal solubility: High molecular weight hyaluronic acid sodium salt is insoluble in ethanol, DMSO, and water.
• Overestimating storage stability: Solutions degrade and should not be stored long-term even at -20°C.
• Misapplying carrier function: Not all cell types efficiently internalize hyaluronic acid-coated nanoparticles due to receptor expression variability.
• Confusing biopolymer effects: Its biological activity is highly concentration- and molecular weight-dependent.
• Ignoring batch variability: Source and production method can affect purity and performance in sensitive assays.

Workflow Integration & Parameters

Effective use of hyaluronic acid sodium salt in experimental workflows requires attention to formulation, concentration, and storage. Below are protocol parameters and workflow suggestions, integrating APExBIO recommendations and recent literature:

Protocol Parameters

• Preparation: Dissolve hyaluronic acid sodium salt (B8382) using gentle agitation in buffered saline at room temperature; avoid ethanol and DMSO as solvents (APExBIO).
• Concentration for in vitro use: Typical working concentration ranges from 10 nM to 1 μM, with optimization based on molecular weight and assay design (product info).
• siRNA nanoparticle coating: Prepare nanoparticles with hyaluronic acid sodium salt as the outer shell for targeted delivery to CD44+ cells; confirm particle size and ζ-potential (Nature Communications 2026).
• Storage: Store dry powder at -20°C; do not freeze or store aqueous solutions long-term.
• Quality control: Monitor molecular weight and endotoxin levels for batch consistency, as per APExBIO B8382 certificate of analysis.

For advanced troubleshooting, see "Advanced ECM and Nanoparticle Workflows", which details practical solutions for maximizing reproducibility; this article adds context around infection models and immune modulation.

Conclusion & Outlook

Hyaluronic acid sodium salt, as supplied by APExBIO and benchmarked in recent studies, is a foundational tool for ECM modeling and nanoparticle-based siRNA delivery. Its dual role as a biophysical matrix component and immune modulator underpins its relevance in infection and tissue repair research. The latest preclinical evidence demonstrates that hyaluronic acid-coated siRNA nanoparticles can modulate neutrophil cuproptosis and improve outcomes in bacterial lung injury (Nature Communications 2026). Future research will likely refine its use for targeted delivery and explore additional signaling effects within defined pathophysiological contexts. For further reading, "HA-Coated siRNA Nanoparticles Target TDRD9" describes earlier immune modulation findings; the present article synthesizes these results with updated, mechanistically detailed evidence.